Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Ermenegildo Zegna NV
ZGN
5
Precision Drilling
PDS
US Stock MarketDetailed Quotes
LXEO Lexeo Therapeutics
- 2.830
- +0.200+7.60%
Close May 13 16:00 ET
93.95MMarket Cap-0.85P/E (TTM)
2.978High2.550Low871.86KVolume2.640Open2.630Pre Close2.45MTurnover4.02%Turnover RatioLossP/E (Static)33.20MShares19.50052wk High1.07P/B61.37MFloat Cap1.45052wk Low--Dividend TTM21.68MShs Float22.330Historical High--Div YieldTTM16.26%Amplitude1.450Historical Low2.814Avg Price1Lot Size
Lexeo Therapeutics News
Lexeo Therapeutics | SCHEDULE 13G/A: Others
Lexeo Therapeutics | SCHEDULE 13G/A: Others
Lexeo Therapeutics | 10-Q: Quarterly report
Lexeo Therapeutics | 8-K: Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights
Lexeo Therapeutics | ARS: Annual Report to Security Holders
Lexeo Therapeutics | DEFA14A: Others
Lexeo Therapeutics | DEF 14A: Definitive information statements
Lexeo Therapeutics | SCHEDULE 13G: Others
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Otero Jose Manuel
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Robertson Jenny
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer See Tai Sandi
Lexeo Therapeutics | 8-K: Current report
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Townsend Richard Nolan
Lexeo Therapeutics | S-8 POS: S-8 POS
Lexeo Therapeutics | 424B5: Prospectus
Lexeo Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Lexeo Therapeutics | 10-K: FY2024 Annual Report
Lexeo Therapeutics | 8-K: Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Robertson Jenny
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Adler Eric
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now